Tapewire

Nasdaq · USD

AFJK

Aimei Health Technology Co., Ltd.

Export transactions ↓
Tapewire entity
7334
SEC CIK
0001979005
Parsed reports
10

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 11, 2025 Filed Feb 11, 2025 19:52 UTC SaleCommon Stock 150,000 $10.86 $1,629,000.00
Disclosure

SEC source: 0000812291-25-000005 · primary_doc.xml · nonDerivative · entry 1

MIZUHO SECURITIES USA LLC · CIK 0000812291 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 550,387

Read SEC document
December 01, 2023 Filed Dec 5, 2023 16:37 UTC PurchaseRights · Derivative 332,000 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001493152-23-043708 · ownership.xml · derivative · entry 2

Aimei Investment Ltd · CIK 0002002807 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 332,000

Underlying: Ordinary shares · Not disclosed shares

Expires not disclosed

F4 · price: The reporting person acquired units, consisting of shares and rights.

F3 · derivative.exercise_date: One right automatically converts into one-fifth (1/5) of one ordinary share upon the consummation of the registrant's initial business combination, as described in the registrant's prospectus filed with the SEC.

F3 · derivative.expiration_date: One right automatically converts into one-fifth (1/5) of one ordinary share upon the consummation of the registrant's initial business combination, as described in the registrant's prospectus filed with the SEC.

F3 · derivative.underlying_shares: One right automatically converts into one-fifth (1/5) of one ordinary share upon the consummation of the registrant's initial business combination, as described in the registrant's prospectus filed with the SEC.

F2 · ownership.direct: Represents rights held by our sponsor Aimei Investment Ltd.. Ms. Huang Han has voting and dispositive power over the rights held of record by our sponsor. Ms. Huang Han disclaims any beneficial ownership of the rights held by our sponsor, except to the extent of her pecuniary interest therein.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 16:37 UTC PurchaseOrdinary Shares 332,000 $10.00 $3,320,000.00
Disclosure

SEC source: 0001493152-23-043708 · ownership.xml · nonDerivative · entry 1

Aimei Investment Ltd · CIK 0002002807 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,905,000

F1 · ownership.direct: Represents shares held by our sponsor Aimei Investment Ltd.. Ms. Huang Han has voting and dispositive power over the shares held of record by our sponsor. Ms. Huang Han disclaims any beneficial ownership of the shares held by our sponsor, except to the extent of her pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.